Plasma biomarkers of Alzheimer’s neuropathy linked to dementia risk
Aug 01, 2024
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.
COVID-19 vaccination may increase risk for urinary tract symptoms
Aug 01, 2024
A higher proportion of those who received a single dose versus three doses had to urinate five or more times in the night.
Most traditional cardiovascular risk factors not linked to migraine
Jul 31, 2024
Current smoking, diabetes mellitus and higher fasting glucose level all were linked to lower prevalence of migraine in women.
58.7 percent of US adults walked for leisure in past week in 2022
Jul 31, 2024
58.7% of adults walked for leisure; 16.2% of adults walked for transportation, with men more likely to do so than women.
Cognitive impairment more often experienced by patients with RA
Jul 31, 2024
People with rheumatoid arthritis with moderate-to-high inflammation also have lower mean values in the Montreal Cognitive Assessment and lower executive function scores.
Methotrexate beneficial for reducing pain, stiffness in knee osteoarthritis
Jul 31, 2024
Significant pain reduction was seen in favor of methotrexate; stiffness and function improved at six months.
Boar’s Head recall tied to listeria expands to 7 million more pounds of deli meat
Jul 31, 2024
“Listeria is especially harmful to people who are pregnant, aged 65 or older, or with weakened immune systems,” the FDA said.
Loss of a loved one during early adulthood linked to biological aging
Jul 30, 2024
Those who experienced two or more losses tended to have older biological ages for several of the epigenetic clocks.
Nasal sprays, behavioral intervention aid in treatment of respiratory illness
Jul 30, 2024
The use of a gel-based spray or saline spray reduced the duration of illness, whereas all interventions cut antibiotic use.
Once-daily TAS-303 superior to placebo for stress urinary incontinence
Jul 30, 2024
TAS-303 had superior efficacy to placebo at week 12 and was associated with only mild or moderate adverse events.